Polidocanol
- Generic Name
- Polidocanol
- Brand Names
- Asclera, Varithena
- Drug Type
- Small Molecule
- Chemical Formula
- C30H62O10
- CAS Number
- 9002-92-0
- Unique Ingredient Identifier
- 0AWH8BFG9A
- Background
Polidocanol is a sclerosing agent indicated to treat uncomplicated spider veins (varicose veins ≤1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity. It is marketed under the brand names Asclera and Varithena. The formula for Polidocanol has the structural formula C12H25(OCH2CH2)nOH, a mean extent of polymerization (n) of approximately 9 and a mean molecular weight of approximately 600.
- Indication
Polidocanol is a sclerosing agent indicated to treat uncomplicated spider veins and uncomplicated reticular veins in the lower extremity.
- Associated Conditions
- Pain caused by Teething, Incompetent accessory saphenous veins, Incompetent great saphenous veins, Superficial venous incompetence, Uncomplicated veins 1 to 3 mm in diameter reticular veins, Uncomplicated veins <1 mm in diameter Spider Veins, Varicosities of the great saphenous vein
Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt
Phase 2
Completed
- Conditions
- Varicose Veins
- Interventions
- Procedure: Endovenous Microfoam Occlusion
- First Posted Date
- 2007-03-01
- Last Posted Date
- 2021-04-21
- Lead Sponsor
- Boston Scientific Corporation
- Target Recruit Count
- 60
- Registration Number
- NCT00442364
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea (OSA) and Snoring Subjects(SS)
Phase 1
- Conditions
- ApneaSnoring
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2006-11-22
- Lead Sponsor
- Liaoyang Central Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT00399451
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath